Alphatec Holdings (ATEC) Net Income towards Common Stockholders (2010 - 2026)
Alphatec Holdings (ATEC) reported Net Income towards Common Stockholders of -$33.9 million for Q1 2026, up 34.68% on a YoY basis from -$25.2 million in Q1 2025, and down 56.04% sequentially from -$21.7 million in Q4 2025.
Alphatec Holdings (ATEC) Net Income towards Common Stockholders (2010 - 2026) Analysis & Trends
Alphatec Holdings (ATEC) has 17 years of Net Income towards Common Stockholders data on file, last reported at -$33.9 million in Q1 2026.
- For the quarter ending Q1 2026, Net Income towards Common Stockholders rose 34.68% year-over-year to -$33.9 million; the trailing twelve-month figure through Mar 2026 stood at -$125.4 million (up 24.27% YoY), and the FY2025 full-year result was -$143.4 million, up 11.57% from the prior year.
- Net Income towards Common Stockholders eased to -$33.9 million in Q1 2026, from -$21.7 million in the prior quarter.
- In the past five years, Net Income towards Common Stockholders ranged from a high of -$21.7 million in Q4 2025 to a low of -$51.9 million in Q1 2025.
- A 5-year average of -$39.8 million and a median of -$40.7 million in 2024 frame the typical range for Net Income towards Common Stockholders.
- Across the five-year window, Net Income towards Common Stockholders tumbled 86.07% in 2022 and jumped 34.81% in 2025, its largest moves.
- Tracing ATEC's Net Income towards Common Stockholders over 5 years: stood at -$34.8 million in 2022, then plunged by 41.1% to -$49.1 million in 2023, then jumped by 32.08% to -$33.3 million in 2024, then jumped by 34.81% to -$21.7 million in 2025, then slumped by 56.04% to -$33.9 million in 2026.
- Business Quant data shows ATEC's Net Income towards Common Stockholders at -$33.9 million in Q1 2026, -$21.7 million in Q4 2025, and -$28.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.01 Bn | 175.72 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 128.76 Bn | 125.88 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 108.90 Bn | 99.68 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 68.43 Bn | 66.98 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 47.96 Bn | 44.29 Bn | 1.29 Bn | - |
| 6 | GE HealthCare Technologies | 28.29 Bn | 26.01 Bn | 1.98 Bn | 411.00 Mn |
| 7 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 199.50 Mn |
| 8 | Smith & Nephew | 26.89 Bn | 26.31 Bn | - | - |
| 9 | Koninklijke Philips | 25.44 Bn | 22.31 Bn | 2.07 Bn | 176.78 Mn |
| 10 | Alphatec Holdings | 1.35 Bn | 1.21 Bn | 136.48 Mn | -33.91 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -33.91 Mn |
| Dec 31, 2025 | -21.73 Mn |
| Sep 30, 2025 | -28.58 Mn |
| Jun 30, 2025 | -41.14 Mn |
| Mar 31, 2025 | -51.91 Mn |
| Dec 31, 2024 | -33.33 Mn |
| Sep 30, 2024 | -39.62 Mn |
| Jun 30, 2024 | -40.68 Mn |
| Mar 31, 2024 | -48.50 Mn |
| Dec 31, 2023 | -49.08 Mn |
| Sep 30, 2023 | -42.65 Mn |
| Jun 30, 2023 | -51.38 Mn |
| Mar 31, 2023 | -43.53 Mn |
| Dec 31, 2022 | -34.78 Mn |
| Sep 30, 2022 | -36.79 Mn |
| Jun 30, 2022 | -37.10 Mn |
| Mar 31, 2022 | -42.62 Mn |
| Dec 31, 2021 | -38.89 Mn |
| Sep 30, 2021 | -43.03 Mn |
| Jun 30, 2021 | -38.21 Mn |